Related Experiment Video
Updated: Oct 26, 2025
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.5K
Neurodevelopment of preterm infants with glucose and sodium abnormalities
Hui-Ying Yang1, Cheng-Han Lee1, Hsiao-Neng Chen1
1Department of Pediatrics, Changhua Christian Children's Hospital, Changhua, Taiwan.
Pediatrics and Neonatology
|August 1, 2021
Summary
High peak serum sodium levels in premature infants are linked to poorer cognitive development. This finding highlights the importance of monitoring electrolytes in very low birth weight infants for long-term neurodevelopmental outcomes.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
- Clinical Chemistry
Background:
- Abnormalities in blood glucose and serum sodium in very low birth weight (VLBW) infants are associated with increased morbidity and mortality.
- Limited data exist on the long-term neurodevelopmental outcomes related to these electrolyte disturbances.
Purpose of the Study:
- To investigate the association between peak and nadir blood glucose and serum sodium levels and neurodevelopmental outcomes in VLBW infants.
- To identify potential risk factors for adverse neurodevelopment in this vulnerable population.
Main Methods:
- A retrospective review of 284 VLBW infants (birth weight <1500 g) was conducted.
- Peak and nadir blood glucose and serum sodium levels during hospitalization were analyzed.
- Neurodevelopmental outcomes were assessed using the Bayley Scales of Infant and Toddler Development, third edition (BSID-III) at 6, 12, and 24 months corrected age.
Main Results:
- A total of 284 VLBW infants were eligible, with follow-up assessments at 6, 12, and 24 months.
- Multiple linear regression analysis revealed significantly lower BSID-III cognitive scores in infants with a peak serum sodium level ≥150 mmol/L compared to those with levels below 150 mmol/L.
Conclusions:
- A peak serum sodium level of ≥150 mmol/L is associated with impaired cognitive outcomes in VLBW infants.
- Further research is needed to establish causality and understand if this association reflects disease severity.
Related Concept Videos
01:27Glucose Transporters
26.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.2K
01:20Inborn Errors of Metabolism
379
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
379
01:20Pathophysiology of Diabetes
2.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
01:22Diabetes Mellitus: Type 2 and Gestational
3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
01:07Teratogenicity
3.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K
01:26Glucose Absorption Into the Small Intestine
33.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
33.3K